Skip to content

Join our newsletter

Donate to MPN-CC

Menu
MPN Cancer Connection logo
Your Future Matters
  • Understanding MPNs
    • General Information
    • An Overview of Myeloproliferative Neoplasms
    • What is Myelofibrosis?
    • What is Polycythemia Vera
    • What is Essential Thrombocythemia
  • Clinical Trials
    • Clinical Trial Finder
    • Search for Clinical Trials
    • Clinical Trial Acronyms and Abbreviations
    • Understanding the Phases of Clinical Trials
  • Our Impact
    • Donate
  • About
    • About Us
    • Our Founder
    • Our Mission
    • MPN-CC Team
    • Corporate Sponsors
  • Resources
    • Patient Resources
    • MPN Experts
    • Advocacy Partners
    • MPN Websites
    • Facebook Groups
    • Treatments
      • Ojjaara
      • Vonjo
      • BESREMi
      • Jakafi
      • INREBIC
  • Blog
    • Blog
  • Contact
Close Menu

MPN Clinical Trial Finder

Clinical Trial Finder

Search Results

Italian Network MDS Registry

Study Purpose

Epidemiological data collection of adult patients affected by myelodysplastic syndrome (MDS) newly diagnosed.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Observational [Patient Registry]
Eligible Ages 18 Years and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - New diagnosis of MDS.

Exclusion Criteria:

- Patient who refuse the signature of informed consent

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT02808858
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Fondazione Italiana Sindromi Mielodisplastiche-ETS
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

N/A
Principal Investigator Affiliation N/A
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Other
Overall Status Recruiting
Countries Italy
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Myelodysplastic-Myeloproliferative Diseases
Additional Details

Development of an Italian regional registries MDS network using the same electronic case report form for data storage, with the following broad aims:

  • - Ability to aggregate and process anonymous epidemiological data collected by individual regional registers; - Ability to aggregate the available data with those of other international registries existing.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

International Sites

Ematologia, AO SS. Antonio e Biagio, Alessandria, AL, Italy

Status

Recruiting

Address

Ematologia, AO SS. Antonio e Biagio

Alessandria, AL, 15121

Site Contact

Flavia Salvi, MD

[email protected]

+39 0131206066

Ancona, AN, Italy

Status

Recruiting

Address

Clinica di Ematologia, AOU Ospedale di Torrette

Ancona, AN, 60020

Site Contact

Antonella Poloni, MD

[email protected]

013120

Genova, GE, Italy

Status

Recruiting

Address

U.O. Clinica Medicina Interna, IRCCS San Martino IST

Genova, GE, 16132

Site Contact

Enrico Balleari, MD

[email protected]

+39 010 5555784

Parma, PR, Italy

Status

Recruiting

Address

Struttura Cattedra di Ematologia e CTMO, AOU di Parma

Parma, PR, 43100

Site Contact

Monica Crugnola, MD

[email protected]

+39 0521-702494

Rionero in Vulture, PZ, Italy

Status

Recruiting

Address

Ematologia e Centro Trapianti, Centro di Riferimento Oncologico della Basilicata

Rionero in Vulture, PZ, 85028

Site Contact

[email protected]

013120

FPO - IRCCS di Candiolo, Candiolo, Torino, Italy

Status

Recruiting

Address

FPO - IRCCS di Candiolo

Candiolo, Torino, 10060

Site Contact

Elena Crisà, MD

[email protected]

0119933250

Torino, TO, Italy

Status

Recruiting

Address

S.C.D.U. Ematologia e Terapie cellulari, Ospedale Mauriziano

Torino, TO, 10128

Site Contact

[email protected]

013120

Ospedale Cardinal Massaia, Asti, Italy

Status

Recruiting

Address

Ospedale Cardinal Massaia

Asti, ,

Site Contact

[email protected]

013120

Ematologia AOU Policlinico di Bari, Bari, Italy

Status

Recruiting

Address

Ematologia AOU Policlinico di Bari

Bari, , 70124

Site Contact

[email protected]

013120

Bologna, Italy

Status

Recruiting

Address

Istituto di Ematologia e Oncologia Medica, Policlinico S.Orsola

Bologna, , 40100

Site Contact

[email protected]

013120

Ematologia- Ospedale Businco, Cagliari, Italy

Status

Recruiting

Address

Ematologia- Ospedale Businco

Cagliari, , 09121

Site Contact

[email protected]

013120

Ospedale Maggiore, Chieri, Italy

Status

Recruiting

Address

Ospedale Maggiore

Chieri, ,

Site Contact

[email protected]

013120

Cattedra di Ematologia Policlino Careggi, Firenze, Italy

Status

Recruiting

Address

Cattedra di Ematologia Policlino Careggi

Firenze, , 50134

Site Contact

[email protected]

013120

Genova, Italy

Status

Recruiting

Address

Dipartimento Emato-Oncologia AOU San Martino Genova

Genova, , 16132

Site Contact

[email protected]

013120

Orbassano, Italy

Status

Recruiting

Address

Medicina interna II Divisione di Ematologia Ospedale S.Luigi Gonzaga

Orbassano, , 10043

Site Contact

[email protected]

013120

Azienda Ospedaliera di Padova, Padova, Italy

Status

Recruiting

Address

Azienda Ospedaliera di Padova

Padova, , 35128

Site Contact

[email protected]

013120

Azienda Ospedaliera Perugia, Perugia, Italy

Status

Recruiting

Address

Azienda Ospedaliera Perugia

Perugia, ,

Site Contact

[email protected]

013120

AOU San Salvatore, Pesaro, Italy

Status

Recruiting

Address

AOU San Salvatore

Pesaro, , 61122

Site Contact

[email protected]

013120

Torino, Italy

Status

Recruiting

Address

Ospedale San Giovanbni Battista-Molinette

Torino, ,

Site Contact

[email protected]

013120

Tricase, Italy

Status

Recruiting

Address

Divisione di Ematologia-Ospedale Cardinale Panico

Tricase, , 73039

Site Contact

[email protected]

013120

Powered By
The content provided on clinical trials is for informational purposes only and is not a substitute for medical consultation with your healthcare provider. We do not recommend or endorse any specific study and you are advised to discuss the information shown with your healthcare provider. While we believe the information presented on this website to be accurate at the time of writing, we do not guarantee that its contents are correct, complete, or applicable to any particular individual situation. We strongly encourage individuals to seek out appropriate medical advice and treatment from their physicians. We cannot guarantee the availability of any clinical trial listed and will not be responsible if you are considered ineligible to participate in a given clinical trial. We are also not liable for any injury arising as a result of participation.

MPN CANCER CONNECTION

is a 501 (c) (3) non-profit public charity, our tax ID number is 47-4839850.

Privacy Policy

Copyright © 2024 MPN Cancer Connection,
All Rights Reserved

Follow us on Social

RSS PV Reporter News

  • Honor those who make a difference in the myeloproliferative neoplasm community: Submit a nomination to the MPN Heroes® Recognition Program today!
  • Precision Medicine in Myeloproliferative Neoplasms (MPNs): Molecular Insights and Advances
  • What Rare Disease Day Means to Me

Recent News

  • Myelofibrosis Treatment: Optimizing JAK Inhibitor Strategies in 2024
  • MPN Research 2024: Emerging Trends

JOIN OUR NEWSLETTER

There was an error. Please try again later.

Success!

  • Sponsors
  • Impact
  • Partners
  • About
  • Contact
  • NCCN Guidelines
  • Terms
  • Privacy

Site by: Kaleidoscopic